Home

About

Advanced Search

Browse by Discipline

Scientific Societies

E-print Alerts

Add E-prints

E-print Network
FAQHELPSITE MAPCONTACT US


  Advanced Search  

 
ATTENTION PHARMACIST: Detach "Patient's Instructions for Use" from package insert and dispense with product.
 

Summary: 1
ATTENTION PHARMACIST: Detach "Patient's Instructions for Use" from package insert
and dispense with product.
Spiriva«
HandiHaler«
(tiotropium bromide
inhalation powder)
FOR ORAL INHALATION ONLY
Rx Only
Prescribing Information
DESCRIPTION
SPIRIVA« HandiHaler« (tiotropium bromide inhalation powder) consists of a capsule dosage
form containing a dry powder formulation of SPIRIVA intended for oral inhalation only with the
HandiHaler inhalation device.
Each light green, hard gelatin capsule contains 18 mcg tiotropium (equivalent to 22.5 mcg
tiotropium bromide monohydrate) blended with lactose monohydrate as the carrier.
The dry powder formulation within the capsule is intended for oral inhalation only.
The active component of SPIRIVA is tiotropium. The drug substance, tiotropium bromide
monohydrate, is an anticholinergic with specificity for muscarinic receptors. It is chemically
described as (1, 2▀, 4▀, 5, 7▀)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-

  

Source: Acton, Scott - Department of Electrical and Computer Engineering, University of Virginia

 

Collections: Computer Technologies and Information Sciences